D57.43 Sickle-cell thalassemia beta zero with crisis

Name of the Condition

• Sickle-cell thalassemia beta zero with crisis

Summary

Sickle-cell thalassemia beta zero with crisis is a genetic blood disorder resulting from the co-inheritance of sickle cell disease and beta zero thalassemia mutations. It causes red blood cells to become abnormal in shape and function, leading to complications such as anemia, pain, and organ damage. The presence of crisis indicates an acute phase with vaso-occlusive episodes.

Causes

Sickle-cell thalassemia arises from co-inheritance of mutations in the hemoglobin gene (HBB). One parent contributes a sickle cell mutation, while the other contributes a beta zero thalassemia mutation. This combination alters hemoglobin structure, resulting in sickle-shaped red blood cells and reduced hemoglobin production.

Risk Factors

• Family history of sickle-cell disease or thalassemia
• Ethnic backgrounds with higher prevalence of these conditions (e.g., Mediterranean, Middle Eastern, Indian, or African descent)
• Inheriting one sickle cell gene and one beta zero thalassemia gene increases the risk of passing the disorder to offspring

Symptoms

• Fatigue and weakness due to anemia
• Jaundice (yellowing of the skin or eyes)
• Swelling in hands and feet (dactylitis)
• Frequent infections
• Delayed growth or puberty in children
• Episodes of severe pain (vaso-occlusive crises)

Diagnosis

Diagnosis involves blood tests to identify sickle-shaped red blood cells and hemoglobin electrophoresis or high-performance liquid chromatography (HPLC) to confirm the specific hemoglobin variants. Genetic testing may be used to identify the beta zero thalassemia mutation.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. This may include pain management during crises, blood transfusions, hydroxyurea to reduce crisis frequency, and folic acid supplementation. In severe cases, bone marrow or stem cell transplantation may be considered.

Prognosis and Follow-Up

Prognosis varies based on the severity of the condition and response to treatment. Regular follow-up with a hematologist is essential to monitor for complications such as organ damage or increased infection risk. Lifelong management is typically required.

Complications

• Acute chest syndrome
• Stroke
• Organ damage (e.g., spleen, liver, kidneys)
• Increased risk of infections
• Pulmonary hypertension

Lifestyle & Prevention

• Stay hydrated to reduce crisis risk
• Avoid extreme temperatures
• Manage stress and get adequate rest
• Follow vaccination schedules to prevent infections
• Avoid smoking and excessive alcohol consumption

When to Seek Professional Help

Seek immediate medical attention for severe pain, difficulty breathing, signs of stroke (e.g., sudden weakness, confusion), or high fever, as these may indicate a crisis or complication.

Tips for Medical Coders

Document the presence of vaso-occlusive crisis and confirm the beta zero thalassemia component to support the use of code D57.43. Ensure clinical documentation aligns with the specific genetic and symptomatic criteria for accurate coding.